 |
|
|
REFERENCES
898.
Alavi JB, Root RK, Djerassi I, et al: A randomized
clinical trial of granulocyte transfusion for infection in acute leukemia. N Engl
J Med 296:706, 1977.
899.
Gabrilove JL, Jakubowski A, Scher H, et al: Effect
of granulocyte colony stimulating factor on neutropenia and associated morbidity
due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J
Med 318:1414, 1988.
900.
Quie PG: The white cells: Use of granulocyte
transfusions. Rev Infect Dis 9:189, 1987.
901.
Crawford SW, Fisher L: Predictive value of pulmonary
function tests before marrow transplantation. Chest 101:1257, 1992.
902.
McCrae KR, Bussel JB, Mannucci PM, et al: Platelets:
An update on diagnosis and management of thrombocytopenic disorders. Hematology
(Am Soc Hematol Educ Program) 282–305, 2001.
903.
Petrovitch CT: The bleeding patient. In
Roizen MF (ed): Anesthesia for Vascular Surgery. New York, Churchill Livingstone,
1990, p 465.
904.
Kelton JG: Management of the pregnant patient
with idiopathic thrombocytopenic purpura. Ann Intern Med 99:796, 1983.
905.
King DJ, Kelton JG: Heparin-associated thrombocytopenia.
Ann Intern Med 100:535, 1984.
906.
Douzinas EE, Markakis K, Karabinis A, et al:
Early plasmapheresis in patients with thrombotic thrombocytopenic purpura. Crit
Care Med 20:57, 1992.
907.
Majerus PW, Miletich JP: Relationships between
platelets and coagulation factors in hemostasis. Annu Rev Med 29:41, 1978.
908.
Lewis BE, Wallis DE, Berkowitz MD, et al: Argatroban
anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation
103:1838–1843, 2001.
909.
Bauer KA: The thrombophilias: Well-defined risk
factors with uncertain therapeutic implications. Ann Intern Med 135:367–373,
2001.
910.
Levine JS, Branch DW, Rauch J: The antiphospholipid
syndrome. N Engl J Med 346:752–763, 2002.
911.
Evans BE: Dental treatment for hemophiliacs:
Evaluation of dental program (1975–1976) at the Mount Sinai Hospital International
Hemophilia Training Center. Mt Sinai J Med 44:409, 1977.
912.
Zauber NP, Levin J: Factor IX levels in patients
with hemophilia B (Christmas disease) following transfusion with concentrates of
factor IX or fresh frozen plasma (FFP). Medicine (Baltimore) 56:213, 1977.
913.
Brettler DB, Levine PH: Factor concentrates for
treatment of hemophilia: Which one to choose? Blood 73:2067, 1989.
914.
Curran JW, Lawrence DN, Jaffe H, et al: Acquired
immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med 310:69,
1984.
915.
Safety of therapeutic products used for hemophilia
patients. MMWR Morb Mortal Wkly Rep 37:441, 1988.
916.
Briere RO: Serum ALT levels: Effect of sex,
race, and obesity on unit rejection rate. Transfusion 28:392, 1988.
917.
Sloand EM, Pitt E, Klein HG: Safety of the blood
supply. JAMA 274:1368, 1995.
918.
Preparation of von Willebrand's factor. Med Lett
Drugs Ther 35:51, 1993.
919.
Miller RD: Complications of massive blood transfusions.
Anesthesiology 39:82, 1973.
920.
Sherman LA: Alterations in hemostasis during
massive transfusion. In Nusbacher J (ed): Massive
Transfusion. Washington, DC, American Association of Blood Banks, 1978, p 51.
921.
Lee KF, Manchell J, Rankin JS, et al: Immediate
versus delayed coronary grafting after streptokinase treatment: Postoperative blood
loss and clinical results. J Thorac Cardiovasc Surg 95:216, 1988.
922.
Dickman CA, Shedd SA, Spetzler RF, et al: Spinal
epidural hematoma associated with epidural anesthesia: Complications of systemic
heparinization in patients receiving peripheral vascular thrombolytic therapy. Anesthesiology
72:947, 1990.
923.
Czer LS, Bateman TM, Gary RJ, et al: Treatment
of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: Reduction
in blood product usage with desmopressin. J Am Coll Cardiol 9:1139, 1987.
924.
Marks RM, Sachar EJ: Undertreatment of medical
inpatients with narcotic analgesics. Ann Intern Med 78:173, 1973.
925.
Brigden ML, Barnett JB: A practical approach
to improving pain control in cancer patients. West J Med 146:580, 1987.
926.
Vitez TS, Way WL, Miller RD, et al: Effect of
delta-9-tetrahydrocannabinol on cyclopropane MAC in the rat. Anesthesiology 38:525,
1973.
927.
Drugs of choice for cancer chemotherapy. Med
Lett Drugs Ther 39:21, 1997.
928.
Bishop JM: Molecular themes in oncogenesis.
Cell 64:235, 1991.
929.
Chung F: Cancer, chemotherapy, and anesthesia.
Can J Anaesth 29:364, 1982.
930.
Goldiner P, Carlon GC, Cvitkovic E, et al: Factors
influencing postoperative morbidity and mortality in patients treated with bleomycin.
BMJ 1:1664, 1978.
931.
Singer MM, Wright F, Stanley LK, et al: Oxygen
toxicity in man: A prospective study in patients after open-heart surgery. N Engl
J Med 283:1473, 1970.
932.
LaMantia KR, Glick JH, Marshall BE: Supplemental
oxygen does not cause respiratory failure in bleomycin-treated surgical patients.
Anesthesiology 60:65, 1984.
933.
Matalon S, Harper WV, Nickerson PA, Olszowka J:
Intravenous bleomycin does not alter the toxic effects of hyperoxia in rabbits.
Anesthesiology 64:614, 1986.
934.
Roizen MF: Is a patient's history of food supplement
use simply supplementary? J Clin Anesth 10:89, 1998.
935.
Weiner N, Taylor P: Neurohumoral transmission
and the autonomic nervous system. In Gilman AG,
Goodman LS, Rall TW, et al (eds): Goodman and Gilman's The Pharmacological Basis
of Therapeutics, 7th ed. New York, Macmillan, 1985, p 66.
936.
Lake CR, Chernow B, Feuerstein G, et al: The
sympathetic nervous system in man: Its evaluation and the measurement of plasma
NE. In Ziegler MG, Lake CR (eds): Norepinephrine.
Baltimore, Williams & Wilkins, 1984, p 1.
937.
Burn JH, Rand MJ: Actions of sympathomimetic
amines on animals treated with reserpine. J Physiol (Lond) 144:314, 1958.
938.
Drugs for hypertension. Med Lett Drugs Ther 37:45,
1995.
939.
Drugs that cause psychiatric symptoms. Med Lett
Drugs Ther 35:65, 1993.
940.
Woodside J Jr, Garner L, Bedford RF, et al: Captopril
reduces the dose requirement for sodium nitroprusside induced hypotension. Anesthesiology
60:413, 1984.
941.
Sethna DH, Gray RJ, Moffitt EA, et al: Dobutamine
and cardiac oxygen balance in patients following myocardial revascularization. Anesth
Analg 61:917, 1982.
942.
The Norwegian Multicenter Study Group: Timolol-induced
reduction in mortality and reinfarction in patients surviving acute myocardial infarction.
N Engl J Med 304:801, 1981.
943.
Frishman WH, Furberg CD, Friedewald WT: β-Adrenergic
blockade for survivors of acute myocardial infarction. N Engl J Med 310:830, 1984.
944.
Smulyan H, Weinberg SE, Howanitz PJ: Continuous
propranolol infusion following abdominal surgery. JAMA 247:2539, 1982.
945.
Slogoff S, Keats AS, Hibbs CW, et al: Failure
of general anesthesia to potentiate propranolol activity. Anesthesiology 47:504,
1977.
946.
Gold MR, Dec GW, Cocca-Spofford DC, Thompson BT:
Esmolol and ventilatory function in cardiac patients with COPD. Chest 100:1215,
1991.
947.
Tanifuji Y, Eger EI II: Effect of isoproterenol
and propranolol on halothane MAC in dogs. Anesth Analg 55:383, 1976.
948.
Bloor BC, Flacke WE: Reduction in halothane anesthetic
requirement by clonidine, an alpha-adrenergic agonist. Anesth Analg 61:741, 1982.
949.
Weinger MB, Segal IS, Maze M: Dexmedetomidine,
acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity
in the rat. Anesthesiology 71:242, 1989.
950.
Ghignone M, Noe C, Calvillo O, Quintin L: Anesthesia
for ophthalmic surgery in the elderly: The effects of clonidine on intraocular pressure,
perioperative hemodynamics, and anesthetic requirement. Anesthesiology 68:707, 1988.
951.
Engelman E, Lipszyc M, Gilbart E, et al: Effects
of clonidine on anesthetic drug requirements and hemodynamic response during aortic
surgery. Anesthesiology 71:178, 1989.
952.
Maze M, Tranquilli W: Alpha-2 adrenoreceptor
agonists: Defining the role in clinical anesthesia. Anesthesiology 74:581, 1991.
953.
Segal IS, Jarvis DJ, Duncan SR, et al: Clinical
efficacy of oral-transdermal clonidine combinations during the perioperative period.
Anesthesiology 74:220, 1991.
954.
Muzi M, Goff DR, Kampine JP, et al: Clonidine
reduces sympathetic activity but maintains baroreflex responses in normotensive humans.
Anesthesiology 77:864, 1992.
955.
Miller RD, Sohn YJ, Matteo RS: Enhancement of
d-tubocurarine neuromuscular blockade by diuretics
in man. Anesthesiology 45:442, 1976.
956.
Katz AM: Cardiac ion channels. N Engl J Med
328:1244, 1993.
957.
Millard RW, Grupp G, Grupp IL, et al: Chronotropic,
inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. Circ
Res 52(Suppl I):I-29, 1983.
958.
Maze M, Mason DM: Verapamil decreases the MAC
for halothane in dogs. Anesth Analg 62:274, 1983.
959.
Reves JG, Kissin I, Lell WA, et al: Calcium entry
blockers: Uses and implications for anesthesiologists. Anesthesiology 57:504, 1982.
960.
Hysing ES, Chelly JE, Doursout M-F: Cardiovascular
effects of and interaction between calcium blocking drugs and anesthetics in chronically
instrumented dogs. III: Nicardipine and isoflurane. Anesthesiology 65:385, 1986.
961.
Merin RG, Chelly JE, Hysing ES, et al: Cardiovascular
effects of and interaction between calcium blocking drugs and anesthetics in chronically
instrumented dogs. IV: Chronically administered oral verapamil and halothane, enflurane,
and isoflurane. Anesthesiology 66:140, 1987.
962.
Kapur PA, Matarazzo DA, Fung DM, Sullivan KB:
The cardiovascular and adrenergic actions of verapamil or diltiazem in combination
with propranolol during halothane anesthesia in the dog. Anesthesiology 66:122,
1987.
963.
Dale J, Landmark KH, Myhre E: The effects of
nifedipine, a calcium antagonist, on platelet function. Am Heart J 105:103, 1983.
964.
Zalman F, Perloff JK, Durant NN, et al: Acute
respiratory failure following intravenous verapamil in Duchenne's muscular dystrophy.
Am Heart J 105:510, 1983.
965.
Zimpfer M, Fitzal S, Tonzcar L: Verapamil as
a hypotensive agent during neuroleptanaesthesia. Br J Anaesth 53:885, 1981.
966.
Durant NN, Nguyen N, Katz RL: Potentiation of
neuromuscular blockade by verapamil. Anesthesiology 60:298, 1984.
967.
Nugent M, Tinker JH, Moyer TP: Verapamil worsens
rate of development and hemodynamic effects of acute hyperkalemia in halothane anesthetized
dogs: Effects of calcium therapy. Anesthesiology 60:435, 1984.
968.
Lalka SG, Rhodes RS, Lina AA, et al: Effect of
calcium entry and β blockade during infrarenal aortic clamping. J Surg Res
46:246, 1989.
969.
Michaels I, Serrins M, Shier NQ, Barash PG: Anesthesia
for cardiac surgery in patients receiving monoamine oxidase inhibitors. Anesth Analg
63:1014, 1984.
970.
Evans-Prosser CDG: The use of pethidine and morphine
in the presence of monamine oxidase inhibitors. Br J Anaesth 40:279, 1968.
971.
Campbell GD: Dangers of monamine oxidase inhibitors.
BMJ 1:750, 1963.
972.
Rogers KJ, Thornton JA: The interaction between
monamine oxidase inhibitors and narcotic analgesics in mice. Br J Pharmacol 36:470,
1969.
973.
Sjoqvist F: Psychotropic drugs. 2. Interaction
between monamine oxidase (MAO) inhibitors and other substances. Proc R Soc Med 58:967,
1965.
974.
Monamine oxidase inhibitors for depression. Med
Lett Drugs Ther 31:11, 1989.
975.
Drugs for psychiatric disorders. Med Lett Drugs
Ther 33:43, 1991.
976.
Roizen MF: Monoamine oxidase inhibitors: Are
we condemned to relive history, or is history no longer relevant? J Clin Anesth
2:293, 1990.
977.
Noble WH, Baker A: MAO inhibitors and coronary
artery surgery: A patient death. Can J Anaesth 39:1061, 1992.
978.
Wells DG, Bjorksten AR: Monoamine oxidase inhibitors
revisited. Can J Anaesth 36:64, 1989.
979.
Hirshman CA, Linderman KS: Anesthesia and monoamine
oxidase inhibitors. JAMA 261:3407, 1989.
980.
Stack CG, Rogers P, Linter SPK: Monoamine oxidase
inhibitors and anaesthesia: A review. Br J Anaesth 60:222, 1988.
981.
El-Ganzouri AR, Ivankovich AD, Braverman B, McCarthy
R: Monoamine oxidase inhibitors: Should they be discontinued preoperatively? Anesth
Analg 64:592, 1985.
982.
Ebrahim ZY, O'Hara JF, Borden L, Tetzlaff J:
Monoamine oxidase inhibitors and elective surgery. Cleve Clin J Med 60:129, 1993.
983.
Clarke AG: MAOI's and Anaesthesia. Can J Anaesth
43:641, 1996.
984.
Edwards RE, Miller RD, Roizen MF, et al: Cardiac
effects of imipramine and pancuronium during halothane and enflurane anesthesia.
Anesthesiology 50:421, 1979.
985.
Veith RC, Raskind MA, Caldwell JH, et al: Cardiovascular
effects of tricyclic antidepressants in depressed patients with chronic heart disease.
N Engl J Med 306:954, 1982.
986.
Richelson E, El-Fakahany E: Changes in the sensitivity
of receptors for neurotransmitters and the actions of some psychotherapeutic drugs.
Mayo Clin Proc 57:576, 1982.
987.
Martin BA, Kramer PM: Clinical significance of
the interaction between lithium and a neuromuscular blocker. Am J Psychiatry 139:1326,
1982.
988.
Johnston RR, Way WL, Miller RD: Alteration of
anesthetic requirements by amphetamine. Anesthesiology 36:357, 1972.
989.
Stoelting RK, Creasser CW, Martz RC: Effect of
cocaine administration on halothane MAC in dogs. Anesth Analg 54:422, 1975.
990.
Katz RL, Bigger JT: Cardiac arrhythmias during
anesthesia and operation. Anesthesiology 33:193, 1970.
991.
Joas TA, Stevens WC: Comparison of the arrhythmic
doses of epinephrine during Forane, halothane and enflurane anesthesia in dogs.
Anesthesiology 35:48, 1971.
992.
Johnston RR, Eger EI II, Wilson C: A comparative
interaction of epinephrine with enflurane, isoflurane and halothane in man. Anesth
Analg 55:709, 1976.
993.
Horrigan RW, Eger EI II, Wilson CB: Epinephrine-induced
arrhythmias during enflurane anesthesia in man: A nonlinear dose-response relationship
and dose-dependent protection from lidocaine. Anesth Analg 57:547, 1978.
994.
Hirshman CA, Bergman NA: Halothane and enflurane
protect against bronchospasm in an asthma dog model. Anesth Analg 57:629, 1978.
995.
Shnider SM, Papper EM: Anesthesia for the asthmatic
patient. Anesthesiology 22:886, 1961.
996.
Marcus ML, Skelton CL, Graver LE, et al: Effects
of theophylline on myocardial mechanics. Am J Physiol 222:1361, 1972.
997.
Westfall DP, Flemming WW: Sensitivity changes
in the dog heart to norepinephrine, calcium and aminophylline resulting from pretreatment
with reserpine. J Pharmacol Exp Ther 159:98, 1968.
998.
Rall TW, West TC: The potentiation of cardiac
inotropic responses to norepinephrine by theophylline. J Pharmacol Exp Ther 139:269,
1963.
999.
Horwitz LN, Spear JF, Moore EN, et al: Effect
of aminophylline on the threshold for initiating ventricular fibrillation during
respiratory failure. Am J Cardiol 35:376, 1975.
1000.
Mitenko PA, Ogilvie RI: Pharmacokinetics of
intravenous theophylline. Clin Pharmacol Ther 14:509, 1973.
1001.
Piafsky KM, Ogilvie RI: Dosage of theophylline
in bronchial asthma. N Engl J Med 292:1218, 1975.
1002.
Hunt SN, Jusko WJ, Yurchak AM: Effect of smoking
on theophylline disposition. Clin Pharmacol Ther 19:546, 1975.
1003.
Takaori M, Loehning RW: Ventricular arrhythmias
induced by aminophylline during halothane anaesthesia in dogs. Can J Anaesth 14:79,
1967.
1004.
Takaori M, Loehning RW: Ventricular arrhythmias
during halothane anaesthesia: Effect of isoproterenol, aminophylline, and ephedrine.
Can J Anaesth 12:275, 1965.
1005.
Roizen MF, Stevens WC: Multiform ventricular
tachycardia due to the interaction of aminophylline and halothane. Anesth Analg
57:738, 1978.
1006.
Stirt JA, Berger JM, Sullivan SF: Lack of arrhythmogenicity
of isoflurane following administration of aminophylline in dogs. Anesth Analg 62:568,
1983.
1007.
Drugs for cardiac arrhythmias. Med Lett Drugs
Ther 38:75, 1996.
1008.
Harrah MD, Way WL, Katzung BG: The interaction
of d-tubocurarine with antiarrhythmic drugs. Anesthesiology
33:406, 1970.
1009.
Telivuo L, Katz RL: The effects of modern intravenous
local anesthetics on respiration during partial neuromuscular block in man. Anaesthesia
25:30, 1970.
1010.
Miller RD, Way WL, Katzung BG: The potentiation
of neuromuscular blocking agents by quinidine. Anesthesiology 28:1036, 1967.
1011.
Pittinger CB, Eryasa Y, Adamson R: Antibiotic-induced
paralysis. Anesth Analg 49:487, 1970.
1012.
Singh YN, Harvey AL, Marshall IG: Antibiotic-induced
paralysis of the mouse phrenic nerve-hemidiaphragm preparation, and reversibility
by calcium and by neostigmine. Anesthesiology 48:418, 1978.
1013.
Pittinger CB, Adamson R: Antibiotic blockade
of neuromuscular function. Annu Rev Pharmacol 12:169, 1972.
1014.
Becker LD, Miller RD: Clindamycin enhances
a non-depolarizing neuromuscular blockade. Anesthesiology 45:84, 1976.
1015.
Snavely SR, Hodges GR: The neurotoxicity of
antibacterial agents. Ann Intern Med 101:92, 1984.
1016.
McIndewar IC, Marshall RJ: Interactions between
the neuromuscular blocking drug Org NC45 and some anaesthetic, analgesic and antimicrobial
agents. Br J Anaesth 53:785, 1981.
1017.
Navalgund AA, Alifimoff JK, Jakymec AJ, Bleyaert
AL: Amiodarone-induced sinus arrest successfully treated with ephedrine and isoproterenol.
Anesth Analg 65:414, 1986.
1018.
Kannan R, Nademane K, Hendrickson JA, et al:
Amiodarone kinetics after oral doses. Clin Pharmacol Ther 31:438, 1982.
1019.
Rice SA, Sbordone L, Mazzo RI: Metabolism by
rat hepatic microsomes of fluorinated ether anesthetics following isoniazid administration.
Anesthesiology 53:489, 1980.
1020.
Beller GA, Smith TW, Abelmann WH, et al: Digitalis
intoxication. N Engl J Med 284:989, 1971.
1021.
Ritchie AJ, Danton M, Gibbons JRP: Prophylactic
digitalisation in pulmonary surgery. Thorax 47:41, 1992.
1022.
Morrow DH: Anesthesia and digitalis toxicity.
VI. Effect of barbiturates and halothane on digoxin toxicity. Anesth Analg 49:305,
1970.
1023.
Pratila MG, Pratilas V: Anesthetic agents and
cardiac electromechanical activity. Anesthesiology 49:338, 1978.
1024.
Logic JR, Morrow DH: The effect of halothane
on ventricular automaticity. Anesthesiology 36:107, 1972.
1025.
Ivankovich AD, Miletich DJ, Grossman RK, et
al: The effect of enflurane, isoflurane, fluroxene, methoxyflurane and diethyl ether
on ouabain tolerance in the dog. Anesth Analg 55:360, 1976.
1026.
Ali N, Dais K, Banks T, Sheikh M: Titrated
electrical cardioversion in patients on digoxin. Clin Cardiol 5:417, 1982.
1027.
Adverse systemic effects from ophthalmic drugs.
Med Lett Drugs Ther 24:53, 1982.
1028.
The Medical Letter Handbook of Adverse Drug
Interactions, 2003.
1029.
Pantuck EJ, Pantuck CB: Cholinesterases and
anticholinesterases. In Katz RL (ed): Muscle Relaxants.
Amsterdam, Excerpta Medica, 1975, p 143.
1030.
Ghonelm MM, Long JP: The interaction between
magnesium and other neuromuscular blocking agents. Anesthesiology 32:23, 1970.
1031.
Del Castillo J, Engback L: The nature of neuromuscular
block produced by magnesium. J Physiol (Lond) 124:370, 1954.
1032.
Feely J, Wilkinson GR, McAllister CB, et al:
Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern
Med 96:592, 1982.
1033.
Lam AM, Parkin JA: Cimetidine and prolonged
postoperative somnolence. Can J Anaesth 28:450, 1981.
1034.
Vessey MD, Doll R, Fairbairn AS, et al: Postoperative
thromboembolism and the use of oral contraceptives. BMJ 3:123, 1970.
1035.
Greene GR, Sartwell PE: Oral contraceptive
use in patients with thromboembolism following surgery, trauma, or infection. Am
J Public Health 62:680, 1972.
1036.
Interruption of a drug regimen before anesthesia.
Med Lett Drugs Ther 16:19, 1974.
1037.
Wyld R, Nimmo WS: Do patients fasting before
and after surgery receive their prescribed drug treatment? BMJ 296:744, 1988.
1038.
Lesar TS, Briceland LL, Delcoure K, et al:
Medication prescribing errors in a teaching hospital. JAMA 263:2329, 1990.
1039.
Halsey MJ: Drug interactions in anaesthesia.
Br J Anaesth 59:112, 1987.
1040.
Update: Drugs in breast milk. Med Lett Drugs
Ther 21:21, 1979.
